Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | FTO | Q9C0B1 | 9/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | SMAD3 | P84022 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL340741 | 0.83 | HPGD (0.63) | HPGDALDH1A1BRCA1HSD17B10ALOX12 | |
| SCHEMBL9130573 | 0.82 | HPGD (0.62) | HPGDALDH1A1BRCA1HSD17B10ALOX12 | |
| SCHEMBL10435860 | 0.82 | HPGD (0.62) | HPGDALDH1A1BRCA1HSD17B10ALOX12 | |
| SCHEMBL8386327 | 0.82 | HPGD (0.51) | HPGDALDH1A1BRCA1HSD17B10ALOX12 | |
| SCHEMBL2839336 | 0.81 | FTO (0.53) | HPGDALDH1A1BRCA1HSD17B10ALOX12 | |
| SCHEMBL6682087 | 0.80 | ALOX12 (0.54) | HPGDALDH1A1BRCA1HSD17B10ALOX12 | |
| SCHEMBL7970057 | 0.80 | HPGD (0.54) | HPGDALDH1A1BRCA1HSD17B10ALOX12 | |
| SCHEMBL8385577 | 0.80 | HPGD (0.51) | HPGDALDH1A1BRCA1HSD17B10ALOX12 | |
| SCHEMBL11773203 | 0.80 | FTO (0.52) | HPGDALDH1A1BRCA1HSD17B10ALOX12 | |
| SCHEMBL8518074 | 0.78 | HPGD (0.51) | HPGDALDH1A1BRCA1HSD17B10ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5100802-A | Fluorescent Dye | THE DOW CHEMICAL COMPANY (US) | 1992-03-31 | — | — | US | claimed |
| US-11953493-B2 | Biophotonic methods for increasing in situ energy production and energy emission in biological cells and tissues | FLE INTERNATIONAL S.R.L. (IT) | 2024-04-09 | — | — | US | disclosed |
| US-11691025-B2 | Methods and compositions for reversing or mitigating skin aging | KLOX TECHNOLOGIES INC. (CA) | 2023-07-04 | — | — | US | disclosed |
| US-20230071297-A1 | POLARIZED FLUORESCENT LIGHT THERAPY SYSTEM AND METHOD | FLE INTERNATIONAL S.R.L. (IT) | 2023-03-09 | — | — | US | disclosed |
| US-20230038408-A1 | BIOPHOTONIC COMPOSITIONS, USES AND METHODS FOR MODULATING MITOCHONDRIAL DYNAMICS AND FUNCTIONALITY IN SKIN AND SOFT TISSUE CONDITIONS | FB DERMATOLOGY S.R.L. (IT) | 2023-02-09 | — | — | US | disclosed |
| US-20220296713-A1 | BIOPHOTONIC COMPOSITIONS FOR TREATING SKIN AND SOFT TISSUE WOUNDS HAVING EITHER OR BOTH NON-RESISTANT AND RESISTANT INFECTIONS | KLOX TECHNOLOGIES LIMITED (IE) | 2022-09-22 | — | — | US | disclosed |
| US-11382977-B2 | Biophotonic compositions for treating skin and soft tissue wounds having either or both non-resistant and resistant infections | VETOQUINOL S.A. (FR) | 2022-07-12 | — | — | US | disclosed |
| US-11207408-B2 | Biophotonic compositions, methods, and kits for inhibiting and disrupting biofilms | KLOX TECHNOLOGIES INC. (CA) | 2021-12-28 | — | — | US | disclosed |
| US-11154532-B2 | Biophotonic compositions for the treatment of otitis externa | VETOQUINOL S.A. (FR) | 2021-10-26 | — | — | US | disclosed |
| US-11141482-B2 | Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease | KLOX TECHNOLOGIES INC. (CA) | 2021-10-12 | — | — | US | disclosed |
| WO-2013092515-A2 | FLUORESCENT POLYACRYLATE DISPERSIONS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-06-27 | — | — | WO | disclosed |
| US-20120245506-A1 | COMBINATION OF AN OXIDANT, A PHOTOSENSITIZER AND A WOUND HEALING AGENT FOR ORAL DISINFECTION AND TREATMENT OF ORAL DISEASE | FLE INTERNATIONAL S.R.L. (IT) | 2012-09-27 | — | — | US | disclosed |
| EP-2453922-A1 | ANTIBACTERIAL ORAL COMPOSITION | Klox Technologies Inc. (CA) | 2012-05-23 | — | — | EP | disclosed |
| EP-2365829-A1 | COMBINATION OF AN OXIDANT AND A PHOTOACTIVATOR FOR THE HEALING OF WOUNDS | Klox Technologies Inc. (CA) | 2011-09-21 | — | — | EP | disclosed |
| US-20110224599-A1 | COMBINATION OF AN OXIDANT AND A PHOTOACTIVATOR FOR THE HEALING OF WOUNDS | FLE INTERNATIONAL S.R.L. (IT) | 2011-09-15 | — | — | US | disclosed |
| US-20110218482-A1 | OXIDATITIVE PHOTOACTIVATED SKIN REJEUVENATION COMPOSITION COMPRISING HYALURONIC ACID, GLUCOSAMINE, OR ALLANTOIN | FLE INTERNATIONAL S.R.L. (IT) | 2011-09-08 | — | — | US | disclosed |
| EP-2352488-A1 | OXIDATITIVE PHOTOACTIVATED SKIN REJEUVENATION COMPOSITION COMPRISING HYALURONIC ACID, GLUCOSAMINE, OR ALLANTOIN | Klox Technologies Inc. (CA) | 2011-08-10 | — | — | EP | disclosed |
| WO-2010051636-A1 | COMBINATION OF AN OXIDANT AND A PHOTOACTIVATOR FOR THE HEALING OF WOUNDS | KLOX TECHNOLOGIES INC . (CA) | 2010-05-14 | — | — | WO | disclosed |
| WO-2010051641-A1 | OXIDATITIVE PHOTOACTIVATED SKIN REJEUVENATION COMPOSITION COMPRISING HYALURONIC ACID, GLUCOSAMINE, OR ALLANTOIN | KLOX TECHNOLOGIES INC. (CA) | 2010-05-14 | — | — | WO | disclosed |
| US-5100802-A | Fluorescent Dye | THE DOW CHEMICAL COMPANY (US) | 1992-03-31 | — | — | US | disclosed |